| Cost benefit data |
Treatments |
| Local |
Local+Captan |
Local+Mancozeb |
Local+Tebuconazole |
Control |
| Marketable yield t ha-1 |
4.04 |
3.67 |
6.1 |
2.24 |
| Price ( $ t-1) |
1,608.58 |
1,608.58 |
1,608.58 |
1,608.58 |
| Sale revenue |
1,343.11 |
316.54 |
526.13 |
193.20 |
| Total input cost ($ ha-1) |
1,343.11 |
1318.03 |
1327.14 |
1,286.86 |
| Marginal cost ($ ha-1) |
56.24 |
31.17 |
40.33 |
00 |
| Net benefit ($ ha-1) |
5155.55 |
4585.45 |
8,485.20 |
2,316.35 |
| Marginal benefit ($ ha-1) |
2839.2 |
2,269.1 |
6,168.84 |
00 |
| Marginal rate of return (%) |
270.67 |
390.34 |
820.22 |
00 |
|
